In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.

Antimicrobial Agents and Chemotherapy
Mahmoud A GhannoumR S Criddle

Abstract

There is currently no rapid, reliable, and reproducible in vitro technique to describe the growth-inhibitory interactions of antifungal drug combinations over a wide range of drug concentrations. We have developed a microdilution plate assay that was used to determine optimal drug combinations and concentrations of one-, two-, and three-drug regimens of amphotericin B (AmphB), fluconazole (FLU), and 5-fluorocytosine (5FC) for growth inhibition of three isolates each of Cryptococcus neoformans and Candida albicans. These growth inhibition data were then used in a multifactorial design technique to (i) generate contour and surface response plots to aid visual interpretation and (ii) develop mathematical equations describing the growth responses of the fungi to a wide range of antifungal concentrations and ratios. Our data indicated that (i) antifungal drug-drug interactions affecting yeast growth are complex functions of the drugs used in combination, their absolute concentrations, and also their relative (proportional) concentrations; (ii) AmphB-FLU combinations had additive effects against C. albicans over wide concentration ranges for each agent but were indifferent (i.e., were less than additive) in their inhibitory effect on...Continue Reading

References

Jul 19, 1979·The New England Journal of Medicine·J E BennettD W Alling
Feb 1, 1978·The Journal of Infectious Diseases·M C Berenbaum
Nov 11, 1992·Journal of Clinical Microbiology·M A GhannoumR S Criddle
Apr 1, 1991·Antimicrobial Agents and Chemotherapy·R AllendoerferJ R Graybill
Oct 1, 1990·Antiviral Research·M N Prichard, C Shipman
Mar 1, 1990·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·R Sabra, R A Branch
Mar 1, 1990·Reviews of Infectious Diseases·K W BrammerJ K Faulkner
Jul 1, 1989·Infection·A Polak
Jan 1, 1989·Annual Review of Pharmacology and Toxicology·M A McKinlay, M G Rossmann
Sep 1, 1985·Reviews of Infectious Diseases·R HornD Armstrong
Sep 1, 1973·Antimicrobial Agents and Chemotherapy·E Titsworth, E Grunberg
Nov 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·G MedoffG S Kobayashi
Mar 1, 1993·Antimicrobial Agents and Chemotherapy·M N PrichardC Shipman

❮ Previous
Next ❯

Citations

Nov 15, 2007·Current Infectious Disease Reports·John W Baddley, Peter G Pappas
Jul 18, 2003·Diagnostic Microbiology and Infectious Disease·Corrado GirmeniaPietro Martino
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Lixin ZhangXiaoping Chen
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Melissa D JohnsonJohn H Rex
Jan 18, 2005·Clinical Microbiology Reviews·Pranab K MukherjeeMahmoud A Ghannoum
Jan 22, 2000·Postgraduate Medical Journal·P Imwidthaya, N Poungvarin
Oct 6, 2012·Annals of Clinical Microbiology and Antimicrobials·Ravikumar B ShindeSankunny M Karuppayil
Jul 22, 2005·Drugs·John W Baddley, Peter G Pappas
Feb 14, 2013·Revista iberoamericana de micología·Tatiana B SpaderSydney Hartz Alves
Nov 1, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Aijaz AhmadNikhat Manzoor
Jul 9, 2004·British Journal of Haematology·Dimitrios P Kontoyiannis, Russell E Lewis
Jul 17, 2010·Journal of Medical Microbiology·Aijaz AhmadNikhat Manzoor
Dec 1, 2010·Osong Public Health and Research Perspectives·Jae Il YooYeong Seon Lee
Aug 15, 2001·Pharmacotherapy·R E Lewis, D P Kontoyiannis
Sep 18, 2004·The Journal of Antimicrobial Chemotherapy·Manuel Cuenca-Estrella
Feb 10, 2021·Journal of Fungi·Anne-Laure BidaudEric Dannaoui
Dec 31, 2002·The Annals of Pharmacotherapy·Staci A Pacetti, Steven P Gelone
Aug 16, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·John R. Perfect, Gary M. Cox
Oct 17, 1998·Journal of Clinical Microbiology·W R KirkpatrickT F Patterson
Nov 1, 1996·Antimicrobial Agents and Chemotherapy·J A VazquezR A Akins
Jun 28, 2019·Journal of Natural Products·Marcelo J Dias SilvaFrancisco A Macías

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.